NCT03832400View on ClinicalTrials.gov

Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 4, 2019

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions

Ulcerative Colitis

Interventions

BIOLOGICAL

MET-2

MET-2 is a defined consortium of human commensal bacteria derived from a healthy donor, which has the full metabolic functional capacity of fecal microbiota.

DRUG

Placebo oral capsule

Placebo oral capsule which is identical to the MET-2 capsules.

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto